A carregar...
Checkpoint Inhibitors: The Diagnosis and Treatment of Side Effects
BACKGROUND: Treatment with checkpoint inhibitors such as anti-programmed death-1 (anti-PD-1), anti-PD-ligand 1 (anti-PD-L1), and anti-cytotoxic T-lymphocyte antigen-4 (anti-CTLA-4) antibodies can prolong the survival of cancer patients, but it also induces autoimmune side effects in 86–96% of patien...
Na minha lista:
| Publicado no: | Dtsch Arztebl Int |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Deutscher Arzte Verlag
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6454802/ https://ncbi.nlm.nih.gov/pubmed/30940340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0119 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|